Construction and validation of a novel prognostic model for postoperative patients with stage I intrahepatic cholangiocarcinoma: a population-based study

构建和验证一种新型的I期肝内胆管癌术后患者预后模型:一项基于人群的研究

阅读:2

Abstract

PURPOSE: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary malignant tumor of the liver. Surgery is routinely recommended for stage I ICC patients. The independent prognostic factors affecting stage I ICC patients after surgery remain unclear. METHODS: Altogether, 349 ICC stage I patients undergoing curative operation from the Surveillance, Epidemiology, and End Results (SEER) database were registered from 2010 to 2021 in this research. Random assignment of these patients was carried out in a 7:3 proportion, forming a training cohort consisting of 245 and an internal validation cohort consisting of 104. Independent prognostic factors were recognized by univariate and multivariate analysis in the training cohort. Subsequently, the prognostic nomogram was constructed using independent prognostic factors in the training cohort, and the nomogram was validated internally and externally using data from the internal validation cohort and a cohort from Eastern Hepatobiliary Surgery Hospital, respectively. RESULTS: Multivariate analysis demonstrated that race, grade, tumor size, and lymph node removal had associations with overall survival (OS) in postoperative patients with stage I ICC in the training cohort (P < 0.05). Then the prognostic nomogram for these patients was constructed on the basis of the above variables. The C-indexes for internal and external validation of the nomogram were 0.65 and 0.63, respectively. In addition, the internally validated and externally validated 1-year, 3-year, and 5-year OS calibration curves exhibited a good fit, suggesting that the nomogram had good predictive power. CONCLUSION: The prognostic nomogram of postoperative patients diagnosed with stage I ICC performs well. This novel nomogram may help clinicians make individualized predictions of postsurgical outcomes for patients with stage I ICC and provide new perspectives for effectively assessing the value of surgery to the patient.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。